RBI
REGN icon

Raiffeisen Bank International’s Regeneron Pharmaceuticals REGN Stock Holding History

Raiffeisen Bank International’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Buy
25,423
+2,220
+10% +$1.51M 0.19% 106
2026
Q1 		$17.4M Buy
23,203
+640
+3% +$490K 0.25% 96
2025
Q4 		$17.5M Buy
22,563
+977
+5% +$663K 0.22% 100
2025
Q3 		$12.1M Buy
21,586
+2,026
+10% +$1.15M 0.16% 116
2025
Q2 		$10.2M Sell
19,560
-540
-3% -$301K 0.15% 119
2025
Q1 		$12.8M Buy
20,100
+15,105
+302% +$10.4M 0.2% 102
2024
Q4 		$3.51M Buy
+4,995
New +$4.19M 0.05% 182

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Raiffeisen Bank International's REGN Position: Q2 2026 in Review

Raiffeisen Bank International increased its Regeneron Pharmaceuticals (REGN) stake by 9.6% in Q2 2026, buying an estimated $1.51M and bringing the position to 25,423 shares worth $16.1M. The position accounts for 0.19% of the portfolio, ranked #106.

Raiffeisen Bank International first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.5M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Raiffeisen Bank International held 25,423 shares of Regeneron Pharmaceuticals worth $16.1M as of Q2 2026.
  • Raiffeisen Bank International bought 2,220 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.51M.
  • Regeneron Pharmaceuticals made up 0.19% of Raiffeisen Bank International's portfolio in Q2 2026, its #106 holding.
  • Raiffeisen Bank International first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Regeneron Pharmaceuticals position peaked at $17.5M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.